Skip to main content

Geffner Michael

Chief Medical Officer

1 company

Insider Signal Score

66
Strong
Trades Analyzed
11
12M Win Rate
66.7%
Avg 3M Return
-4.6%
Avg 12M Return
+12.4%

Geffner Michael serves as a Chief Medical Officer at IMVT. Across recent SEC filings that breaks down to 0 buys and 12 sells. Those positions are worth an estimated $8.9M at current prices.

Historically, Geffner Michael's trades have earned a middling insider score of 66/100 across 11 rated trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +12.4%.

The biggest single holding is IMVT (~$8.9M) as Chief Medical Officer. The recent filings there lean toward selling, a net 38,594 shares.

Holdings by Company

IMVTOct 22, 2025
Current Shares218.0K
Value$8.92M
Net Activity-38,594
Bought: 0Sold: 38.6K

Transaction History

Showing 10 filings
DateTickerRoleTypeSharesPriceValueChg%3M12MSEC
Oct 22, 2025
IMVT
Immunovant, Inc.
Chief Medical OfficerSell2,595$19.03$49,382.85-1.2%+38.3%-
Oct 8, 2025
IMVT
Immunovant, Inc.
Chief Medical OfficerSell1,272$16.30$20,733.60-0.6%+61.1%-
Jul 23, 2025
IMVT
Immunovant, Inc.
Chief Medical OfficerSell2,385$18.15$43,287.75-1.1%+4.6%-
Jul 9, 2025
IMVT
Immunovant, Inc.
Chief Medical OfficerSell1,160$17.24$19,998.40-0.5%-6.8%-
Apr 23, 2025
IMVT
Immunovant, Inc.
Chief Medical OfficerSell2,349$14.79$34,741.71-1.0%+24.2%-
Apr 9, 2025
IMVT
Immunovant, Inc.
Chief Medical OfficerSell6,169$12.99$80,135.31-2.6%+13.4%+72.1%
Jan 22, 2025
IMVT
Immunovant, Inc.
Chief Medical OfficerSell2,657$23.59$62,678.63-2.0%-38.7%+12.7%
Oct 23, 2024
IMVT
Immunovant, Inc.
Chief Medical OfficerSell3,189$29.53$94,171.17-2.3%-21.4%-37.6%
Jul 24, 2024
IMVT
Immunovant, Inc.
Chief Medical OfficerSell3,456$27.76$95,938.56-2.4%+5.9%-34.4%
Apr 24, 2024
IMVT
Immunovant, Inc.
Chief Medical OfficerSell3,261$28.90$94,242.90-2.3%-2.8%-47.7%
Page 1Next →

Understand these filings